Dicerna Pharmaceuticals, Inc.

RNA Therapy Market Set to Reach $4.16 Billion by 2034 as Clinical Trials Accelerate

5 months ago

• The global RNA therapy clinical trials market is projected to grow from $2.85 billion in 2024 to $4.16 billion by 2034, with a CAGR of 3.85%, driven by advancements in mRNA, siRNA, and antisense oligonucleotide-based therapies. • Over 80 companies are currently evaluating more than 100 RNA therapies across various development stages, with significant activity in rare diseases, oncology, and genetic disorders. • Recent breakthroughs include FDA clearance for the first CRISPR/Cas13 RNA-editing therapy for neovascular age-related macular degeneration and promising results for RNA therapies targeting rare muscular dystrophies.